This is my most exciting recruitment project yet. Innovative and pioneering, Synthego, a provider of synthetic RNA solutions for CRISPR Genome Engineering, are looking to grow their team.
This biotech provide powerful genome engineering solutions across Engineered Cell Lines, CRISPR-Cas9 kits & libraries and Bioinformatic platforms.
To establish their European commercial force, they’re now hunting for two Strategic Account Managers – one in the DACH region and one in North Germany.
Synthego pride themselves on providing a complete array of cost-efficient solutions that enable the highest precision and reliability in genome editing, recognised around the world by prestigious institutes and industry leaders.
Delivering year on year growth at 3.5X, they’ve raised a healthy $160M in Series C funding and are now searching for someone equally passionate about the CRISPR-Cas9 revolution.
Offering unrivalled compensation and earning potential - coupled with clear routes for progression – get in touch and find out what Synthego can do for you.
In this episode, our specialist in the lab equipment space, Lucy Smith, spoke with CEO of Elementar Americas Ryan Titmas. Lucy spoke to Ryan about what it takes to get to the top, as well as some of the lessons he’s learned in his career so far.
Even if you’ve been through the process, you may not be aware of exactly what goes into M&A deals. Today, we’ve tried to look into that in a little more detail with Transaction Liability Team Leader Grant Hollis from CFC Underwriting,
One of the biggest partnering events in the life science calendar Bio-Europe Spring, was scheduled to take place in Paris from March 23 – 27 this year. That all changed with the emergence of COVID-19...